Associate Professor of Neurology, Duke University
Nipocalimab Shows Promise as Myasthenia Gravis Treatment: Jeffrey Guptill, MD, MS, MHS
The associate professor of neurology and neurologist at Duke University discussed the positive results of nipocalimab, a monoclonal antibody, in patients with myasthenia gravis.
Overviewing 2025 Baptist Health Brain and Spine Symposium: Exploring New Options in Chronic Pain Management
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Newborn Screening, Enzyme Delivery, and the Future of Pompe Disease Treatment
AMX0035 Continues to Stabilize and Improve Wolfram Syndrome at 48 Weeks, Phase 2 HELIOS Trial Shows